Equity Analysis /
United States of America

US : Biotechnology - Biotechnology | Here's Our Methodology for Estimating COVID Vaccine Efficacy

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    15 January 2021
    Published byCGS-CIMB

    This is our first methodological attempt at predicting COVID vaccine efficacy. Using our regression analysis we are predicting efficacy for:JNJ (~60% for single shot, closer to 80% for prime-boost; data this month);NVAX (>90%, data 1Q21 Ex U.S. from South Africa and U.K. studies and 2Q21 from U.